🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary purpose of this study is to compare the progression-free surviv...
Status
Suspended
Location
Bond Clinic, P.A.
Start Date
2022-05-12
Trial ID
NCT05378763
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of samurac...
Status
Completed
Location
Ocala Oncology Center PL DBA Florida Cancer Affiliates
Start Date
2023-11-16
Trial ID
NCT05963984
Treatments Being Tested
EGF is a polypeptide that promotes cell differentiation and collagen produc...
Status
Completed
Location
Institute of Dermatology
Start Date
2023-01-30
Trial ID
NCT05724589
Treatments Being Tested
The purpose of this study is to investigate the response rate of cetuximab ...
Status
Completed
Location
Asan Medical Center
Start Date
2008-03
Trial ID
NCT00637091
Treatments Being Tested
The primary purpose of this trial is to evaluate the efficacy and tolerabil...
Status
Unknown
Location
St George Hospital
Start Date
2018-10-23
Trial ID
NCT03994393
Treatments Being Tested
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking the enz...
Status
Completed
Location
University of Texas Health Science Center San Antonio
Start Date
2002-06
Trial ID
NCT00045487
Treatments Being Tested
This randomized phase II trial studies how well erlotinib hydrochloride (Ta...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2012-03-16
Trial ID
NCT01532089
Treatments Being Tested
This is a multicenter, international, open-label, single-arm, multicohort, ...
Status
Completed
Location
Champalimaud Center for the Unknown
Start Date
2020-05-25
Trial ID
NCT04420598
Treatments Being Tested
This is an open-label, multicenter, Phase Ib dose-escalation study designed...
Status
Terminated
Location
Multiple Locations
Start Date
2009-11
Trial ID
NCT00996892
Treatments Being Tested
This is a Phase 1 study during which patients with advanced HER2+ solid mal...
Status
Completed
Location
The University of Colorado Cancer Center
Start Date
2008-05
Trial ID
NCT00650572
Treatments Being Tested